Be inspired by colleagues who have protected their innovation and achieved commercial success. Addressing unmet needs: innovating to support youngsters with ADHD Dr Aja Murray's primary research interests relate to mental health phenotypes and their co-occurrence from a developmental perspective. With the support from our iTPA team and others she built a prototype digital health interventions (DHIs) app for ADHD. Building Partnerships with Professor Colin Pulham Professor Colin Pulham from the School of Chemistry, discusses his research interests and the collaboration with Sunamp. He also talks about the benefits of engaging with industry from the School's and researchers' perspectives. Doug Gibson, laying the foundations for success Dr Doug Gibson, Sir Henry Dale Fellow in the Centre for Inflammation Research (CIR), centres his research around endometrial repair, a process essential to female reproductive health. Dr Sarah Morton tackles sedentary behaviours One of the many impacts of the COVID-19 pandemic has been a substantial shift in how people with desk-based roles do their jobs. Technology protection impact The Roslin Institute and animal genetics company Genus have signed a licensing agreement to breed disease-resistant pigs. Turning research breakthrough into new potential medicines Nuvectis Pharma has an exclusive license to develop new cancer treatments based on protected University research. This article was published on 2024-07-01
